Cargando…

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome

BACKGROUND: Genome-wide interrogation of DNA methylation (DNAm) in blood-derived leukocytes has become feasible with the advent of CpG genotyping arrays. In epithelial ovarian cancer (EOC), one report found substantial DNAm differences between cases and controls; however, many of these disease-assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridley, Brooke L, Armasu, Sebastian M, Cicek, Mine S, Larson, Melissa C, Wang, Chen, Winham, Stacey J, Kalli, Kimberly R, Koestler, Devin C, Rider, David N, Shridhar, Viji, Olson, Janet E, Cunningham, Julie M, Goode, Ellen L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102255/ https://www.ncbi.nlm.nih.gov/pubmed/24774302 http://dx.doi.org/10.1186/1755-8794-7-21

Ejemplares similares

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
por: Koestler, Devin C, et al.
Publicado: (2014)

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
por: Natanzon, Yanina, et al.
Publicado: (2018)

Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
por: Wang, Chen, et al.
Publicado: (2016)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015)

Subject level clustering using a negative binomial model for small transcriptomic studies
por: Li, Qian, et al.
Publicado: (2018)

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
por: Earp, Madalene A, et al.
Publicado: (2017)

Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes
por: Peedicayil, Abraham, et al.
Publicado: (2010)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014)

Single versus multiple imputation for genotypic data
por: Fridley, Brooke L, et al.
Publicado: (2009)

Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational Research
por: Cicek, Mine S., et al.
Publicado: (2020)

Assessment of data transformations for model-based clustering of RNA-Seq data
por: Noel-MacDonnell, Janelle R., et al.
Publicado: (2018)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer
por: Chien, Jeremy, et al.
Publicado: (2018)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer
por: Raghavan, Rama, et al.
Publicado: (2016)

An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Meier, Richard, et al.
Publicado: (2016)

Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
por: Larson, Nicholas B, et al.
Publicado: (2014)

A Curated Cancer Clinical Outcomes Database (C3OD) for accelerating patient recruitment in cancer clinical trials
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2018)

Assessment of genotype imputation methods
por: Biernacka, Joanna M, et al.
Publicado: (2009)

A Latent Model for Prioritization of SNPs for Functional Studies
por: Fridley, Brooke L., et al.
Publicado: (2011)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013)

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
por: Way, Gregory P., et al.
Publicado: (2016)

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
por: Basal, Eati, et al.
Publicado: (2009)

Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer
por: Goode, Ellen L., et al.
Publicado: (2013)

No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
por: Goode, Ellen L, et al.
Publicado: (2009)

Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
por: Chien, Jeremy, et al.
Publicado: (2013)

DNA Methylation in Ovarian Cancer Susceptibility
por: Reid, Brett M., et al.
Publicado: (2020)

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
por: Mehner, Christine, et al.
Publicado: (2017)

Metformin is synthetically lethal with glucose withdrawal in cancer cells
por: Khurana, Ashwani, et al.
Publicado: (2012)

Gender Bias in Human Systemic Lupus Erythematosus: A Problem of Steroid Receptor Action?
por: Rider, Virginia, et al.
Publicado: (2018)

Analysis of variation in NF-κB genes and expression levels of NF-κB-regulated molecules
por: Liu-Mares, Wen, et al.
Publicado: (2007)

Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
por: Kelemen, Linda E., et al.
Publicado: (2012)

TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
por: Chien, Jeremy, et al.
Publicado: (2015)

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
por: Ross-Adams, Helen, et al.
Publicado: (2016)

Comparison of tagging single-nucleotide polymorphism methods in association analyses
por: Goode, Ellen L, et al.
Publicado: (2007)

The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods
por: de Andrade, Mariza, et al.
Publicado: (2007)

Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
por: Hathcock, Matthew A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cjjrnl3ti9q5qpdntpqbqce3jt